Pricing

Cougar Biotechnology Inc (CGRB)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BLANK CHECKS
210 SOUTH FEDERAL HIGHWAY DEERFIELD BEACH, FL 33441

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Cougar Biotechnology, Inc., a development stage biopharmaceutical company, engages in the acquisition and development of therapeutics for the treatment of cancer. It owns the rights to three clinical stage drug candidates, including CB-7630, a targeted inhibitor of the steroidal enzyme for the treatment of advanced prostate cancer patients; CB-3304, an inhibitor of microtubules and tubulin for the treatment of hematological malignancies; and CB-1089, an analog of vitamin D for various tumors, including prostate, breast, pancreas, colon, skin, and brain cancer. The company is also conducting preclinical development of CB-6604, an extended version of CB-3304 for in-vitro studies in breast cancer cells.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available